Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opzelura
Pharma
Pfizer plots Litfulo vitiligo filings, pressuring Incyte, AbbVie
Pfizer is headed to regulators with results from a pair of late-stage studies testing its would-be Opzelura rival Litfulo in nonsegmental vitiligo.
Fraiser Kansteiner
Jul 30, 2026 2:15pm
Incyte expects Opzelura to cross $1B in 2026
Jul 29, 2026 10:30am
Europe's CHMP reverses endorsement of Amgen's Tavneos
Jun 26, 2026 11:07am
CMS, Incyte settle lawsuit on classification of Opzelura
Jun 23, 2026 1:32pm
Incyte reports Opzelura sales up 33% in 2025, plots '26 growth
Feb 10, 2026 11:48am
Incyte taps Winnie Harlow to model vitiligo awareness
Dec 2, 2025 12:05pm
